Cargando…
Comparison of Remimazolam-Flumazenil versus Propofol for Rigid Bronchoscopy: A Prospective Randomized Controlled Trial
Background: Remimazolam is a novel ultrashort-acting intravenous benzodiazepine sedative–hypnotic that significantly reduces the times to sedation onset and recovery. This trial was conducted to confirm the recovery time from anesthesia of remimazolam-flumazenil versus propofol in patients undergoin...
Autores principales: | Pan, Yafei, Chen, Mo, Gu, Fulei, Chen, Jinyan, Zhang, Wen, Huang, Zhangxiang, Zhu, Dapeng, Song, Jia, Fang, Jun, Yu, Weifeng, Xie, Kangjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821250/ https://www.ncbi.nlm.nih.gov/pubmed/36615057 http://dx.doi.org/10.3390/jcm12010257 |
Ejemplares similares
-
Comparison of the recovery profile of remimazolam with flumazenil and propofol anesthesia for open thyroidectomy
por: Lee, Ho-Jin, et al.
Publicado: (2023) -
Remimazolam and low-dose flumazenil for awake craniotomy
por: Murata, Hiroaki, et al.
Publicado: (2022) -
Postoperative infusion of dexmedetomidine via intravenous patient-controlled analgesia for prevention of postoperative delirium in elderly patients undergoing surgery
por: Xie, Kangjie, et al.
Publicado: (2023) -
Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation
por: Araki, Hideharu, et al.
Publicado: (2023) -
Postoperative Heart Failure with Preserved Ejection Fraction Induced by Flumazenil Administered for Remimazolam Antagonism
por: Koh, Keito, et al.
Publicado: (2022)